Market Tracker

04/17 6:05pm ET

Vical Inc (NASDAQ:VICL)

1.20
Data as of Apr 17
 -0.03 / -2.44%
Today’s Change
1.01
Today|||52-Week Range
4.51
+1.69%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close1.23
Today’s open1.22
Day’s range1.17 - 1.23
Volume690,133
Average volume (3 months)1,444,353
Market cap$102.4M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+37.86%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.94%
P/E ratioNM
Price/Sales13.28
Price/Book1.67

Competitors

 Today’s
change
Today’s
% change
TNXPTonix Pharmaceutical...+0.06+0.60%
LPCNLipocine Inc+0.03+0.38%
GTXIGTX Inc-0.04-2.94%
AQXPAquinox Pharmaceutic...-0.13-1.47%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$7.7M
Annual profit (last year)-$31.2M
Net profit margin-404.74%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, CFO &
Director
Vijay B. Samant
Vice President-
Vaccine Research
Larry R. Smith
Corporate headquarters
San Diego, California

Forecasts